Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Finished Goods (2016 - 2024)

Historic Finished Goods for Utah Medical Products (UTMD) over the last 14 years, with Q4 2024 value amounting to $1.9 million.

  • Utah Medical Products' Finished Goods rose 1353.12% to $1.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.9 million, marking a year-over-year increase of 1353.12%. This contributed to the annual value of $1.9 million for FY2024, which is 1353.12% up from last year.
  • Latest data reveals that Utah Medical Products reported Finished Goods of $1.9 million as of Q4 2024, which was up 1353.12% from $1.4 million recorded in Q3 2024.
  • In the past 5 years, Utah Medical Products' Finished Goods registered a high of $2.5 million during Q2 2023, and its lowest value of $1.1 million during Q2 2021.
  • Moreover, its 5-year median value for Finished Goods was $1.5 million (2021), whereas its average is $1.6 million.
  • Its Finished Goods has fluctuated over the past 5 years, first crashed by 6101.47% in 2020, then surged by 5536.37% in 2023.
  • Quarter analysis of 5 years shows Utah Medical Products' Finished Goods stood at $1.4 million in 2020, then grew by 7.7% to $1.5 million in 2021, then grew by 29.16% to $1.9 million in 2022, then dropped by 11.13% to $1.7 million in 2023, then increased by 13.53% to $1.9 million in 2024.
  • Its Finished Goods was $1.9 million in Q4 2024, compared to $1.4 million in Q3 2024 and $1.3 million in Q2 2024.